Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ningxia Zhongke Biotechnology Co Days Payable Chart
SHSE:600165 vs LIN, SHW, ECL: Days Payable Comparison
For the Specialty Chemicals subindustry, Ningxia Zhongke Biotechnology Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ningxia Zhongke Biotechnology Co Days Payable vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Ningxia Zhongke Biotechnology Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Ningxia Zhongke Biotechnology Co's Days Payable falls into.
Ningxia Zhongke Biotechnology Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ningxia Zhongke Biotechnology Co (SHSE:600165) has a Days Payable of 98.62 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Ningxia Zhongke Biotechnology Co and its competitors. This is 72% below median its historical median of 350.44. Over the past decade, Ningxia Zhongke Biotechnology Co's Days Payable has ranged from 36.91 to 995.18. According to the industry distribution chart, Ningxia Zhongke Biotechnology Co ranks #32 out of 1554 companies in the Chemicals industry, placing it in the top 2.1%.
Is Ningxia Zhongke Biotechnology Co's Days Payable too high?
Ningxia Zhongke Biotechnology Co's current Days Payable of 98.62 is 72% below median its 10-year median of 350.44. Over the past 10 years, this metric has ranged from a low of 36.91 to a high of 995.18. The Chemicals industry median Days Payable is 59.57. Ningxia Zhongke Biotechnology Co's value of 98.62 is 65.6% above this industry median. Based on the distribution chart, Ningxia Zhongke Biotechnology Co ranks #32 out of 1554 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Ningxia Zhongke Biotechnology Co has a GF Score™ of 53/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ningxia Zhongke Biotechnology Co's Days Payable compare to LIN and SHW?
According to the Chemicals industry distribution chart, Ningxia Zhongke Biotechnology Co ranks #32 out of 1554 companies for Days Payable. This places Ningxia Zhongke Biotechnology Co in the top 2% of its industry — outperforming the majority of peers. The industry median Days Payable is 59.57. Ningxia Zhongke Biotechnology Co's value of 98.62 is 65.6% above this benchmark. Historically, Ningxia Zhongke Biotechnology Co's own Days Payable has ranged from 36.91 to 995.18 over the past decade. While the company's 10-year median is 350.44 vs. the industry median of 59.57, Ningxia Zhongke Biotechnology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Chemicals company?
The median Days Payable among Chemicals companies is 59.57, based on 1,554 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ningxia Zhongke Biotechnology Co's current Days Payable of 98.62 is 65.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Ningxia Zhongke Biotechnology Co and its competitors. For the Chemicals industry, the median Days Payable is 59.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ningxia Zhongke Biotechnology Co's current Days Payable is 98.62, which is 72% below median its own 10-year median of 350.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ningxia Zhongke Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Ningxia Zhongke Biotechnology Co (SHSE:600165) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥2.77, compared to a current price of ¥2.43 — trading 12.3% below its estimated fair value. The current Days Payable is 98.62, which is 72% below median its 10-year median of 350.44 and 65.6% above the Chemicals industry median of 59.57. Ningxia Zhongke Biotechnology Co's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Ningxia Zhongke Biotechnology Co (SHSE:600165), the current Days Payable is 98.62 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ningxia Zhongke Biotechnology Co (SHSE:600165) Overvalued in 2026?
Based on GuruFocus' analysis, Ningxia Zhongke Biotechnology Co stock appears to be undervalued.
The current stock price of ¥2.43 is trading 12.3% below its estimated GF Value™ of ¥2.77.
GuruFocus considers Ningxia Zhongke Biotechnology Co to be Modestly Undervalued.
Key valuation signals for SHSE:600165:
Days Payable: 98.62 (72% below median its 10-year median of 350.44)
GF Value™: ¥2.77 vs. price of ¥2.43 (12.3% below fair value)
Industry Position: 65.6% above the Chemicals median (#32 of 1554)
No single metric tells the full story. See the SHSE:600165 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ningxia Zhongke Biotechnology Co Business Description
Ningxia Zhongke Biotechnology Co Ltd is engaged in the production and sales of activated carbon products, preparation and storage of stem cells, trade and other businesses, as well as lauric acid.
53GF Score
Get the complete analysis for SHSE:600165
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600165 has been successfully added to your 
